Volume 3, Issue 6: Cure of Hepatitis B: Is it Achievable? - PODCAST
e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 3, Issue 6)
Nurses and health care professionals involved in the care of patients with Hepatitis.
After participating in this activity, the participant will demonstrate the ability to:
- Describe expectations in terms of hepatitis B surface antigen loss with nucleotide/nucleoside therapies, alone or in combination with interferon.
- Explain the risk factors for the development of hepatocellular carcinoma after hepatitis B surface antigen clearance.
- Discuss non-eradication of the HBV genome and reactivation after surface antigen clearance.
Fabien Zoulim, MD, PhD
Professor, Head of INSERM Viral Hepatitis Laboratory
Medical School of Lyon, Lyon 1 University
Hepatology Department, Hospices Civils de Lyon
- 0.50 ANCC